Metraipolis › archive › dc_f0b86591ef3c

Novel cutaneous adverse effects of the increasingly prevalent glucagon-like peptide 1 agonists — Europe PMC PMID:42813201

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42813201
DOI
10.1093/skinhd/vzag090
License (as archived)
solo-consultazione
Archived
2026-10-18T11:01:37.346Z
SHA-256 of the archived text
3a48ab634a1d7cfa7c41bb7c6bbdb26994f54ce382f0caa828b564900d3ef85f
Stable URL of this page
https://metraipolis.com/documento/dc_f0b86591ef3c

How to cite

Novel cutaneous adverse effects of the increasingly prevalent glucagon-like peptide 1 agonists — Europe PMC PMID:42813201 — Europe PMC (en), https://europepmc.org/article/MED/42813201 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f0b86591ef3c (Metraipolis archive dc_f0b86591ef3c, sha256 3a48ab634a1d7cfa7c41bb7c6bbdb26994f54ce382f0caa828b564900d3ef85f)
BibTeX
@misc{dcf0b86591ef3c,
  title = {Novel cutaneous adverse effects of the increasingly prevalent glucagon-like peptide 1 agonists — Europe PMC PMID:42813201},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42813201},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f0b86591ef3c; sha256 3a48ab634a1d7cfa7c41bb7c6bbdb26994f54ce382f0caa828b564900d3ef85f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42813201. Agents can read the archived copy with the MCP tool read_document.